Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$8,663,209
+$1,211,350 QoQ
Shares Held
34,427
+0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#998
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL CITY TRUST CO/FL holds $25,072,255 across 7 Drug Manufacturers - General names. ABBV ranks #2 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,666 | $10,327,943 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
34,427 | $8,663,209 | |
| 3 | AMGN |
Amgen Inc
|
6,238 | $2,258,903 | |
| 4 | LLY |
ELI LILLY & Co
|
1,257 | $1,507,683 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
23,154 | $1,334,133 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,790 | $615,515 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,888 | $364,869 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,663,209 | 34,427 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $7,451,859 | 34,263 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,950,766 | 34,797 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,193,505 | 35,387 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $6,982,281 | 37,616 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $7,844,638 | 37,441 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,572,767 | 36,988 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $7,229,939 | 36,611 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,174,719 | 36,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,611,867 | 36,309 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,800,836 | 37,432 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $5,492,413 | 36,847 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $5,457,777 | 40,509 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,694,814 | 42,008 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $6,734,773 | 41,673 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,652,656 | 42,118 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $6,413,880 | 41,877 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $6,817,049 | 42,052 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $5,725,659 | 42,287 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $4,545,965 | 42,143 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $4,689,315 | 41,631 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $4,434,638 | 40,978 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,268,426 | 39,836 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $3,426,870 | 39,124 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $3,677,037 | 37,452 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,496,669 | 32,769 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||